Last Updated: Jul 14, 2016
- Challenges of development and implementation of point of care pharmacogenetic testing.
Haga Susanne B et al. Expert review of molecular diagnostics 2016 Jul - Predicting Response Trajectories during Cognitive-Behavioural Therapy for Panic Disorder: No Association with the BDNF Gene or Childhood Maltreatment.
Santacana Martí, et al. PloS one 2016 0 (6) e0158224 - Role of cytochrome P450 2D6 genetic polymorphism in carvedilol hydroxylation in vitro.
Wang Zhe, et al. Drug design, development and therapy 2016 0 1909-16 - EMR Documentation of Physician-Patient Communication Following Genomic Counseling for Actionable Complex Disease and Pharmacogenomic Results.
Sweet Kevin et al. Clinical genetics 2016 Jun - Virtual Pharmacist: A Platform for Pharmacogenomics.
Cheng Ronghai et al. PloS one 2015 10(10) e0141105 - The frequency of SLCO1B1*5 polymorphism genotypes among Russian and Sakha (Yakutia) patients with hypercholesterolemia.
Sychev Dmitrij Alekseevitch, et al. Pharmacogenomics and personalized medicine 2016 0 59-63 - Phenome-wide association study maps new diseases to the human major histocompatibility complex region.
Liu Jixia, et al. Journal of medical genetics 2016 6 - Implementation of Electronic Consent at a Biobank: An Opportunity for Precision Medicine Research.
Boutin Natalie T et al. Journal of personalized medicine 2016 6(2) - Sequenom, the U.S. Supreme Court, and Personalized Medicine.
Kodroff Cathy A et al. Human gene therapy. Clinical development 2016 Jun - The financial hazard of personalized medicine and supportive care.
Carrera Pricivel M et al. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2015 Dec 23(12) 3399-401 - Genetics of movement disorders in the next-generation sequencing era.
Olgiati Simone et al. Movement disorders : official journal of the Movement Disorder Society 2016 Apr 31(4) 458-70 - Personalized medicine leads to better outcomes for patients with cancer,
EurekAlert, June 6, 2016 - What are people willing to pay for whole-genome sequencing information, and who decides what they receive?
Marshall Deborah A et al. Genetics in medicine : official journal of the American College of Medical Genetics 2016 Jun - A Personalized Approach to Parkinson's Disease Patients Based on Founder Mutation Analysis.
Giladi Nir, et al. Frontiers in neurology 2016 0 71 - How does pharmacogenetic testing alter the treatment course and patient response for chronic-pain patients in comparison with the current "trial-and-error" standard of care?
DeFeo Kelly et al. Journal of the American Association of Nurse Practitioners 2014 Oct 26(10) 530-6
- Human (335)
- Pathogen (0)
- Guidelines (2)
- Tier Table (0)
- Synthesis (23)
- Huamn (2)
- Pathogen (0)
.png)
No hay comentarios:
Publicar un comentario